Clinical Trials | July 27, 2022
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
Better serving global partners and advancing healthcare innovation
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Manish led SeQuent since 2014 and played a major role in transforming the company
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Subscribe To Our Newsletter & Stay Updated
